SINGAPORE, Jan. 24, 2022 /PRNewswire/ Concept Medical Inc., focused on vascular intervention drug delivery devices, shares the latest status of its IMPRESSION (sIroliMus coated balloon angioPlasty versus plain balloon angioplasty in the tREatment of dialySis acceSs dysfunctION) randomized controlled trial (RCT), as it crosses the 50 per cent enrollment mark. IMPRESSION randomized trial enrolled its index patient.
SINGAPORE, Jan. 24, 2022 /PRNewswire/ Concept Medical Inc., focused on vascular intervention drug delivery devices, shares the latest status of its IMPRESSION (sIroliMus coated balloon angioPlasty
SINGAPORE, Jan. 24, 2022 /PRNewswire/ - Concept Medical Inc., focused on vascular intervention drug delivery devices, shares the latest status of its - Report on The Eastern Herald
/PRNewswire/ Concept Medical Inc., focused on vascular intervention drug delivery devices, shares the latest status of its IMPRESSION (sIroliMus coated.